MicroVention Terumo

About:

MicroVention Terumo develops catheter-based neuroendovascular technologies for cerebral aneurysms and other neurovascular diseases.

Website: http://microvention.com

Top Investors: U.S. Venture Partners, Advanced Technology Ventures, DeNovo Ventures, Asset Management Company, Crosspoint Venture Partners

Description:

MicroVention Terumo is a medical device company. It develops catheter-based and minimally-invasive neuroendovascular technologies for cerebral aneurysms and other neurovascular diseases. The company’s products include delivery and detachment systems, access products, intraluminal devices, occlusion balloons, and flow diverters, as well as polymer, platinum, and hydrogel coil products. MicroVention Terumo offers its products through a network of specialty distributors primarily in North America, South America, Europe, Africa, the Middle East, and Asia Pacific. Founded in 1997, MicroVention Terumo is based in Tustin, California. As of March 30, 2006, it operates as a subsidiary of Terumo Corporation.

Total Funding Amount:

$51.6M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Tustin, California, United States

Founded Date:

1997-01-01

Founders:

Brian J. Cox, Robert Rosenbluth

Number of Employees:

1001-5000

Last Funding Date:

2003-09-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai